James Besser - Net Worth and Insider Trading
James Besser Net Worth
The estimated net worth of James Besser is at least $11 Million dollars as of 2024-09-20. James Besser is the Director or Senior Officer of 10% Security Holder of Eupraxia Pharmaceuticals Inc and owns about 2,784,049 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) stock worth over $11 Million. Details can be seen in James Besser's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that James Besser has not made any transactions after 2022-05-10 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of James Besser
James Besser Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, James Besser owns 1 companies in total, including Eupraxia Pharmaceuticals Inc (TSX:EPRX) .
Click here to see the complete history of James Besser’s form 4 insider trades.
Insider Ownership Summary of James Besser
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TSX:EPRX | Eupraxia Pharmaceuticals Inc | 2022-05-10 | Director or Senior Officer of 10% Security Holder |
James Besser Latest Holdings Summary
James Besser currently owns a total of 1 stock. James Besser owns 2,784,049 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) as of May 10, 2022, with a value of $11 Million.
Latest Holdings of James Besser
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TSX:EPRX | Eupraxia Pharmaceuticals Inc | 2022-05-10 | 2,784,049 | 3.90 | 10,857,791 |
Holding Weightings of James Besser
James Besser Form 4 Trading Tracker
According to the SEC Form 4 filings, James Besser has made a total of 1 transactions in Eupraxia Pharmaceuticals Inc (TSX:EPRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Eupraxia Pharmaceuticals Inc is the acquisition of 150,000 shares on May 10, 2022, which cost James Besser around $159,000.
Insider Trading History of James Besser
- 1
James Besser Trading Performance
GuruFocus tracks the stock performance after each of James Besser's buying transactions within different timeframes. To be detailed, the average return of stocks after 1 year bought by James Besser is 613%. GuruFocus also compares James Besser's trading performance to market benchmark return within the same time period. The performance of stocks bought by James Besser within 1 year outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how James Besser's insider trading performs compared to the benchmark.
Performance of James Besser
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 12 | | | | | |
| Relative Return to S&P 500(%) | 14.5 | | | | | |
James Besser Ownership Network
James Besser Owned Company Details
What does Eupraxia Pharmaceuticals Inc do?
Who are the key executives at Eupraxia Pharmaceuticals Inc?
James Besser is the Director or Senior Officer of 10% Security Holder of Eupraxia Pharmaceuticals Inc. Other key executives at Eupraxia Pharmaceuticals Inc include Senior Officer Amanda Michelle Malone , Senior Officer Paul Anthony Brennan , and Director or Senior Officer of 10% Security Holder Morgan Frank .
Eupraxia Pharmaceuticals Inc (TSX:EPRX) Insider Trades Summary
Over the past 18 months, James Besser made no insider transaction in Eupraxia Pharmaceuticals Inc (TSX:EPRX). Other recent insider transactions involving Eupraxia Pharmaceuticals Inc (TSX:EPRX) include a net purchase of 5,000 shares made by Amanda Michelle Malone , a net purchase of 3,800 shares made by Michael Wilmink , and a net purchase of 6,100 shares made by James Allen Helliwell .
In summary, during the past 3 months, insiders sold 0 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) in total and bought 1,900 shares, with a net purchase of 1,900 shares. During the past 18 months, 0 shares of Eupraxia Pharmaceuticals Inc (TSX:EPRX) were sold and 24,900 shares were bought by its insiders, resulting in a net purchase of 24,900 shares.
Eupraxia Pharmaceuticals Inc (TSX:EPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eupraxia Pharmaceuticals Inc Insider Transactions
James Besser Mailing Address
Above is the net worth, insider trading, and ownership report for James Besser. Currently GuruFocus does not have mailing address information for James Besser.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
